Determination to check the Efficacy Of Duralabhadi Choorna Comparison With Vidangadi Choorna In Vataja Kasa (Tropical Pulmonary Eosinophillia)

Phase 2

Completed

• Conditions: Health Condition 1: J393- Upper respiratory tract hypersensitivity reaction, site unspecified

• Registration Number: CTRI/2023/05/052767
• Lead Sponsor: shalini

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1.patient presenting with sign and symptom of Vataja Kasa.

2.Absolute Eosinophilia count more than 400 cells /cumm in the peripheral blood smear.

Exclusion Criteria

1.patients having complaints of carcinoma of respiratory system , pulmonary tuberculosis ,pleurisy , lung collapse ,ILD , pneumonia , pneumothorax .

2.Troical Pulmonary Eosinophila with complication / secondary infection / asthma syndromes are excluded .

3.patient suffering from disease like bronchical asthma , pneumonia , other eosinophilic lung and on going treatment of tropical pulmonary Eosinophilia are excluded.

4.patients having chief complaints of vataja kasa ( tropical pulmonary eosinophilia ) more than 2 years and having history of and depending on steriods , bronchodilator drug history .

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decrease the Eosinophil countTimepoint: 21 days .

Secondary Outcome Measures

Name	Time	Method
Improvement in TLC , DLC , HB% , decrease in Eosinophil count by 2-3 units.Timepoint: 21 days